Found 5 matching trials
Study to Evaluate the Safety and Efficacy of Selonsertib, Firsocostat, Cilofexor, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) PHASE2 The primary objectives of this study are:
* To assess the safety and toler...
Show More Location
The Institute for Liver Health
Learn More & Join Trial
Safety and Tolerability of Cilofexor in Participants With Primary Sclerosing Cholangitis (PSC) and Compensated Cirrhosis PHASE1 The primary objective of this study is to assess the safety and tolerabilit...
Show More Location
Arizona Liver Health
Learn More & Join Trial
Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH) PHASE2 The primary objective of this study is to evaluate the safety and tolerabil...
Show More Location
Arizona Liver Health
Learn More & Join Trial
Cilostazol and Endothelial Progenitor Cell PHASE4 To assess impact of adjunctive cilostazol on endothelial progenitor cell (E...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) PHASE2 The goal of this clinical study is to understand whether the study drugs, s...
Show More Location
University of Alabama at Birmingham Hospital
Learn More & Join Trial